MAIA
MAIA Biotechnology Inc.
NYSE MKT: MAIA · HEALTHCARE · BIOTECHNOLOGY
$1.30
+4.00% today
Updated 2026-04-29
Market cap
$75.23M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.70
Dividend yield
—
52W range
$1 – $3
Volume
0.9M
MAIA Biotechnology Inc. (MAIA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | $1.73M | $746505.00 | $11.33M | $12.02M | $7.57M | $10.16M |
| Cash & equivalents | $1.71M | $663457.00 | $10.57M | $10.95M | $7.15M | $9.60M |
| Current assets | $1.73M | $746505.00 | $10.67M | $11.81M | $7.56M | $10.15M |
| Total liabilities | $409737.00 | $2.36M | $2.15M | $3.51M | $7.09M | $6.52M |
| Current liabilities | $374565.00 | $1.69M | $2.15M | $3.27M | $4.94M | $3.83M |
| Long-term debt | — | $431801.00 | — | — | — | — |
| Shareholder equity | $-172867.00 | $-3.34M | $9.18M | $8.51M | $477511.00 | $3.63M |
| Retained earnings | $-9.30M | $-15.93M | $-28.44M | $-44.21M | $-63.98M | $-87.23M |
| Accounts receivable | — | — | $43666.00 | $302789.00 | $144680.00 | $77347.00 |
| Inventory | — | — | $-43666.00 | — | — | — |
| Goodwill | — | — | — | — | — | — |